Massar Capital Management, LP

Massar Capital Management, LP is a New York, NY–based hedge fund and commodity trading advisor specializing in systematic global macro and managed-futures strategies. Founded in the mid‑2010s by Marwan Younes, who serves as Founder and Chief Investment Officer, the firm focuses on liquid global markets across interest rates, foreign exchange, equity indices, commodities, and volatility. Massar Capital manages pooled investment vehicles and managed accounts for institutional allocators and sophisticated private investors, including pensions, endowments and foundations, funds of funds, family offices, and high-net-worth individuals. Its investment programs are implemented through quantitative models that seek to capture macro trends, cross-asset relative value, and other systematic risk premia, with tight risk management and diversification across instruments and time frames. The firm files Form 13F with the U.S. Securities and Exchange Commission under CIK 0002037238 because certain of its programs and accounts hold reportable long positions in U.S.-listed equities and equity-linked instruments above the SEC’s disclosure threshold. These positions typically arise from index and sector ETFs or specific equity exposures used within broader macro portfolios, and represent only a slice of Massar’s total risk footprint, which is dominated by futures, forwards, and other derivatives not captured by Form 13F. Within a holdings-analytics context, Massar’s 13F filings provide a regulator-sourced window into its U.S. equity-related exposures at quarter-end—principally how it expresses or offsets macro views through listed equity and ETF positions. Aggregating those filings into a 13F History allows allocators to examine the equity-sleeve implementation alongside the firm’s stated systematic macro remit. Tools such as a Portfolio Simulator or Backtesting Service can then be applied to the 13F dataset to create a holdings-based Historical Track Record for the long U.S. equity sleeve, always interpreted as secondary to the firm’s broader derivatives-driven activities.

Massar Capital’s core mandate is quantitative global macro and managed futures. The investment process is model-driven and systematic, targeting opportunities across major liquid asset classes. The firm’s strategies typically blend trend-following components with other macro and relative-value signals, seeking to benefit from persistent price dynamics, shifts in monetary and fiscal regimes, and cross-market dislocations. Key elements of the investment philosophy include: - Multi-asset diversification, with positions in global interest-rate futures, FX forwards, equity index futures, commodity futures, and volatility products. - Use of statistically grounded signals—such as time-series momentum, carry, value, and macro-sensitive indicators—combined in a risk-budgeted portfolio construction framework. - Active risk management, including volatility targeting, dynamic position sizing, and constraints on concentration, correlation, and tail exposure. The long U.S. equity positions visible in Massar’s 13F filings are an implementation detail of this broader systematic macro process. Rather than expressing idiosyncratic single-stock views, the 13F sleeve is typically composed of: - Broad-based index ETFs (e.g., large- and mid-cap U.S. equity benchmarks) used to express directional or hedging views on equity beta. - Sector or factor ETFs that align with model signals about relative value or trend across equity sectors or styles. - Occasional single-stock or ADR positions where liquidity, index inclusion, or technical considerations justify direct exposure. As a result, the 13F-visible book should be interpreted as the equity and ETF overlay within a multi-asset systematic macro portfolio. It does not capture the main directional and relative-value futures positions that drive the strategy’s macro expression. For allocators analyzing Massar via public data, the most robust way to infer implementation is to examine 13F Portfolio Composition through time: the mix between index and sector ETFs, the presence or absence of concentrated single-name exposure, and the evolution of equity beta proxies in different macro environments. A 13F-focused Portfolio Simulator can then translate these quarter-end holdings into a reconstructed capital trajectory for the equity sleeve, normalized to a user-defined starting notional. This historical replication offers insight into how Massar’s macro views, as expressed through U.S. equity instruments, have interacted with changing regimes in equity markets.

Massar Capital Management, LP (CIK 0002037238) is a New York–based, quantitatively driven global macro and managed-futures manager whose 13F footprint arises from its use of U.S.-listed equities and ETFs as part of a larger multi-asset trading architecture. The firm’s core expertise lies in systematic macro models applied across rates, FX, equity indices, commodities, and volatility; the 13F equity sleeve is a complementary expression of these views rather than a stand-alone stock-picking strategy. From an allocator’s perspective, Massar’s 13F record can still be analytically informative when used within an advanced 13F analytics platform: - Time-series inspection of 13F Portfolio Composition clarifies how index versus sector ETFs, and any single-name exposures, are used to implement equity overlays and hedges. - A holdings-based Historical Track Record, constructed via a Portfolio Simulator or Backtesting Service and normalized to a user-chosen notional, maps the capital trajectory of the U.S. equity sleeve associated with Massar’s macro views. - The reconstructed series supports a detailed Volatility Profile and calculation of Sharpe Ratio, summarizing how the equity component’s variability and risk-adjusted outcomes compare with broad benchmarks in different macro and market regimes. Because Form 13F omits the bulk of Massar’s activity—futures, forwards, swaps, options, and non-U.S. instruments—these analytics should be integrated with broader macro and derivatives disclosures rather than interpreted in isolation. The central diagnostic question for allocators is how Massar’s equity overlays, as revealed through their 13F History and reconstructed capital behavior, respond to shifts in volatility, interest-rate trends, and cross-asset correlations, and whether that regime sensitivity complements the rest of a multi-asset portfolio’s existing macro exposures.

Massar Capital’s overall risk profile is that of a systematic macro and managed-futures manager: highly diversified across assets and geographies, with explicit volatility targets and risk budgets, and the potential to provide convexity or crisis-response characteristics in sustained macro trends. At the program level, drawdowns have historically been associated with range-bound, choppy markets where directional trends and cross-asset relationships are unstable, while strong macro regimes can support pronounced positive compounding behavior. Within the narrower lens of Form 13F, only the long U.S. equity and ETF sleeve is observable. Risk characteristics of this slice typically include: - Beta exposure to U.S. and, indirectly, global equity markets through index ETFs and related instruments. - Time-varying net exposure, as the systematic process adjusts its views on equities relative to other asset classes. - Limited single-name idiosyncratic risk if the book is primarily implemented via diversified ETFs, with risk dominated by overall equity-market moves. By converting Massar’s 13F filings into a time series of equity-sleeve values—rescaled to an arbitrary starting capital—allocators can estimate realized variability and summarize it as a Volatility Profile. This reveals how the long U.S. equity component has fluctuated relative to broad equity benchmarks, and whether Massar’s macro process tends to run equity overlays that are more conservative, comparable, or more aggressive than a simple index proxy. Comparing this reconstructed equity-sleeve capital path against an appropriate benchmark also allows for the estimation of risk-adjusted outcomes such as Sharpe Ratio. These metrics, derived from 13F-based historical replication or Performance Backtests Online, quantify how effectively the firm’s systematic macro views—when expressed through U.S.-listed equity instruments—have transformed variability into long-run capital growth within that sleeve. However, they do not capture short positions, futures, FX, commodities, or rate exposures that are central to Massar’s strategy-level risk and compounding behavior. It is therefore essential to view any 13F-based risk analysis as partial: it describes only the realized path of the reportable U.S. equity instruments embedded in a much broader, multi-asset trading program. Full assessment of Massar’s risk profile requires integrating this information with knowledge of the futures- and FX-based components disclosed in other regulatory filings and investor materials.